Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of XP12B in Women With Menorrhagia

ClinicalTrials.gov ID: NCT00401193

Public ClinicalTrials.gov record NCT00401193. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.

Study identification

NCT ID
NCT00401193
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
304 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
May 2008 (Actual)
Completion
May 2008 (Actual)
Last update posted
May 13, 2015

2006 – 2008

United States locations

U.S. sites
83
U.S. states
35
U.S. cities
79
Facility City State ZIP Site status
Investigative Site Birmingham Alabama 35209 —
Investigative Site Phoenix Arizona 85015 —
Investigative Site Tucson Arizona 85710 —
Investigative Site Tucson Arizona 85712 —
Investigative Site Little Rock Arkansas 72205 —
Investigative Site Searcy Arkansas 72143 —
Investigative Site Los Alamitos California 90720 —
Investigative Site Los Angeles California 90027 —
Investigative Site San Diego California 92108 —
Investigative Site Denver Colorado 80202 —
Investigative Site Groton Connecticut 06340 —
Investigative Site Gainesville Florida 32610 —
Investigative Site Jacksonville Florida 32216 —
Investigative Site Lighthouse PT Florida 33064 —
Investigative Site Miami Florida 33186 —
Investigative Site Miami Beach Florida 33141 —
Investigative Site New Port Richey Florida 34652 —
Investigative Site Sarasota Florida 34233 —
Investigative Site Atlanta Georgia 30328 —
Investigative Site Decatur Georgia 30033 —
Investigative Site Boise Idaho 83712 —
Investigative Site Idaho Falls Idaho 83404 —
Investigative Site Bloomington Indiana 47403 —
Investigative Site Newton Kansas 67114 —
Investigative Site Overland Park Kansas 66215 —
Investigative Site Marrero Louisiana 70072 —
Investigative Site Baltimore Maryland 21230 —
Investigative Site Ann Arbor Michigan 48106 —
Investigative Site Bingham Farms Michigan 48025 —
Investigative Site Grand Rapids Michigan 49506 —
Investigative Site Paw Paw Michigan 49079 —
Investigative Site Saint Clair Shores Michigan 48081 —
Investigative Site Kansas City Missouri 64114 —
Investigative Site Missoula Montana 59808 —
Investigative Site McCook Nebraska 69001 —
Investigative Site Las Vegas Nevada 89128 —
Investigative Site Lawrenceville New Jersey 08648 —
Investigative Site Moorestown New Jersey 08057 —
Investigative Site New Brunswick New Jersey 08903 —
Investigative Site Albuquerque New Mexico 87131 —
Investigative Site New York New York 10017 —
Investigative Site Rochester New York 14621 —
Investigative Site Durham North Carolina 27713 —
Investigative Site Raleigh North Carolina 27607 —
Investigative Site Winston-Salem North Carolina 27103 —
Investigative Site Bismarck North Dakota 58501 —
Investigative Site Cleveland Ohio 44121 —
Investigative Site Cleveland Ohio 44122 —
Investigative Site Gallipolis Ohio 45631 —
Investigative Site Zanesville Ohio 43701 —
Investigative Site Oklahoma City Oklahoma 73104 —
Investigative Site Oklahoma City Oklahoma 73112 —
Investigative Site Eugene Oregon 97401 —
Investigative Site Portland Oregon 97205 —
Investigative Site Levittown Pennsylvania 19056 —
Investigative Site Philadelphia Pennsylvania 19104 —
Investigative Site Philadelphia Pennsylvania 19114 —
Investigative Site Phoenixville Pennsylvania 19460 —
Investigative Site Strafford Pennsylvania 19087 —
Investigative Site Wexford Pennsylvania 15090 —
Investigative Site Wynnewood Pennsylvania 19096 —
Investigative Site Greenville South Carolina 29605 —
Investigative Site Sioux Falls South Dakota 57104 —
Investigative Site Bristol Tennessee 37620 —
Investigative Site Clarksville Tennessee 37043 —
Investigative Site Nashville Tennessee 37203 —
Investigative Site Austin Texas 78737 —
Investigative Site Bryan Texas 77802 —
Investigative Site Fort Worth Texas 76132 —
Investigative Site Houston Texas 77030 —
Investigative Site Plano Texas 75093 —
Investigative Site Temple Texas 46502 —
Investigative Site The Woodlands Texas 77380 —
Investigative Site Waco Texas 76712 —
Investigative Site Webster Texas 77598 —
Investigative Site Pleasant Grove Utah 84062 —
Investigative Site Salt Lake City Utah 84124 —
Investigative Site West Jordan Utah 84088 —
Investigative Site West Valley City Utah 84120 —
Investigative Site Burlington Vermont 05401 —
Investigative Site Norfolk Virginia 23502 —
Investigative Site Richmond Virginia 23225 —
Investigative Site Renton Washington 98055 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00401193, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2015 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00401193 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →